Jason Funt
Jason Funt
Immuneering Corporation
Verified email at alum.mit.edu
Title
Cited by
Cited by
Year
The evolution of drug resistance in clinical isolates of Candida albicans
CB Ford, JM Funt, D Abbey, L Issi, C Guiducci, DA Martinez, T Delorey, ...
elife 4, e00662, 2015
2052015
Determinants of divergent adaptation and Dobzhansky-Muller interaction in experimental yeast populations
JB Anderson, J Funt, DA Thompson, S Prabhu, A Socha, C Sirjusingh, ...
Current Biology 20 (15), 1383-1388, 2010
832010
Y MAP: a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens
DA Abbey, J Funt, MN Lurie-Weinberger, DA Thompson, A Regev, ...
Genome medicine 6 (11), 1-16, 2014
512014
Comparing the biological impact of glatiramer acetate with the biological impact of a generic
F Towfic, JM Funt, KD Fowler, S Bakshi, E Blaugrund, MN Artyomov, ...
PloS one 9 (1), e83757, 2014
422014
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
J Kim, J Zhang, Y Cha, S Kolitz, J Funt, RE Chong, S Barrett, R Kusko, ...
Journal of translational medicine 18 (1), 1-9, 2020
322020
Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets
KD Fowler, JM Funt, MN Artyomov, B Zeskind, SE Kolitz, F Towfic
Scientific reports 5 (1), 1-14, 2015
162015
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids
S Kolitz, T Hasson, F Towfic, JM Funt, S Bakshi, KD Fowler, D Laifenfeld, ...
Scientific reports 5 (1), 1-14, 2015
142015
Characterizing a glatiramer acetate related drug product
R Schwartz, S Bakshi, KD Fowler, FG Towfic, JM Funt, BJ Zeskind, ...
US Patent App. 14/147,167, 2014
112014
Calculation of the entropy of lattice polymer models from Monte Carlo trajectories
RP White, J Funt, H Meirovitch
Chemical physics letters 410 (4-6), 430-435, 2005
112005
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
S Melamed-Gal, P Loupe, B Timan, V Weinstein, S Kolitz, J Zhang, J Funt, ...
Eneurologicalsci 12, 19-30, 2018
72018
Metastasis: Leveraging transcriptomics to identify potential therapeutics
M Ung, JM Funt, AC Lysaght, J Zhang, R Escalante-Chong, G Koytiger, ...
Cancer Research 78 (13 Supplement), 5177-5177, 2018
22018
Cachexia: Leveraging transcriptomics to identify potential therapeutics
M Ung, KD Fowler, JM Funt, R Escalante-Chong, G Koytiger, S Kolitz, ...
Cancer Research 78 (13 Supplement), 1509-1509, 2018
22018
Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
B Zeskind, KD Fowler, JM Funt, F Towfic, SE Kolitz
US Patent App. 14/904,279, 2016
22016
Gene expression studies comparing glatiramer acetate and proposed generics (P1. 212)
B Zeskind, F Towfic, J Funt, K Fowler, S Bakshi, E Blaugrund, S Kolitz, ...
Neurology 82 (10 Supplement), 2014
22014
Coronavirus Disease-2019 (COVID-19)
J Kim, J Zhang, Y Cha, S Kolitz, J Funt, RE Chong, S Barrett, B Zeskind, ...
ChemRxiv, 2019
12019
Integrity, standards, and QC-related issues with big data in pre-clinical drug discovery
JF Brothers II, M Ung, R Escalante-Chong, J Ross, J Zhang, Y Cha, ...
Biochemical pharmacology 152, 84-93, 2018
12018
Genomic profiling and in vivo rat toxicity characterization of Copaxone and the Synthon European follow-on glatiramer acetate product
S Kolitz, N Ashkenazi, B Timan, J Zhang, J Funt, O Beriozkin, A Konya, ...
MULTIPLE SCLEROSIS JOURNAL 24, 940-941, 2018
2018
Physicochemical and Biological Characterization of both Copaxone and the European Follow-On Glatiramer Acetate Product (P1. 400)
B Timan, A Komlosh, O Beriozkin, A Konya, K Wells-Knecht, V Weinstein, ...
Neurology 90 (15 Supplement), 2018
2018
Abstract B027: A meta-metastasis analysis identifies pan-cancer markers and therapeutic targets
KD Fowler, JM Funt, S Kolitz, J Zhang, M Ung, R Escalante-Chong, ...
Molecular Cancer Therapeutics 17 (1 Supplement), B027-B027, 2018
2018
Improving pancreatic cancer drug discovery by leveraging genomics to select better in vitro models
Y Cha, J Perez-Rogers, A Lysaght, B Weiner, S Kolitz, F Towfic, J Funt, ...
Cell 10, C3, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20